After 30 years, scientists finally have a drug for a deadly brain disease
The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function and even improving movement in some patients.
Read original article on Mind & Brain News -- ScienceDaily →Related news
-
Triple-action drug retatrutide delivers major weight loss for people with diabetes, Phase III trial finds
United Kingdom
-
Technology-assisted approach can help prevent summer weight gain in adolescents
United Kingdom
-
Why managing vibration is critical in IVF
United Kingdom
-
Neck stiffness puts pitchers at risk of throwing-related injuries
United Kingdom
-
AI tool reveals what attracts immune cells to tumors and what keeps them away
United Kingdom
-
New research shows reduced toxicant exposure reduces biological activity
United Kingdom
-
AI screening helps more people with diabetes access sight-saving eye care
United Kingdom
-
Exposure to 'safer' plastic additive during pregnancy linked to smaller birth size
United Kingdom